Atlas Trials

Acrotech Biopharma Inc.

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Acrotech Biopharma Inc.

RecordFirmDate
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL (NCT06072131)Acrotech Biopharma Inc.2023-10-04
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment (NCT07036133)Acrotech Biopharma Inc.2022-12-28
This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) (NCT05608343)Acrotech Biopharma Inc.2022-10-01
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis (NCT05571943)Acrotech Biopharma Inc.2022-09-15
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients (NCT04243434)Acrotech Biopharma Inc.2020-08-15
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials (NCT04184869)Acrotech Biopharma Inc.2019-08-05

Track Acrotech Biopharma Inc. automatically

Every clearance here is in the API, with alerts when new ones post.